V. Stangl et al., Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia, EUR J PHARM, 377(1), 1999, pp. 43-50
The role of adenosine and prostacyclin in post-ischemic vasodilation was in
vestigated using a model of sequential perfusion of two isolated hearts. Tw
o guinea pig hearts were sequentially perfused (10 ml/min) without (control
, n = 4) or with preceding 10-min ischemia (n = 6) of Heart I. Under contro
l conditions no hemodynamic changes were observed in Heart II during sequen
tial perfusion. After 10 min of ischemia of Heart I coronary perfusion pres
sure decreased by 23% in Heart IT at the onset of sequential perfusion. Ade
nosine A(1) and A(2) receptor antagonists 1,3-dipropyl-8-cyclopentylxanthin
e (DPCPX) (2 mu M) and 3,7-dimethyl-1-propargylxanthine (DMPX) (20 mu M) in
fused simultaneously inhibited this decrease in coronary perfusion pressure
by 74%, whereas indomethacin (5 mu M) had no effect. DPCPX, DMPX and indom
ethacin in combination induced a significant increase in coronary perfusion
pressure. Adenosine release (HPLC) into the coronary effluent after ischem
ia was significantly enhanced in the presence of indomethacin. These result
s suggest that after myocardial ischemia prostacyclin has an inhibitory eff
ect on adenosine release. (C) 1999 Elsevier Science B.V. All rights reserve
d.